Natalie Dickson, MD

Research Reports

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting

02/15/2018

Michael A. Savin , MD;

Ravi Salgia , MD, PhD;

Blase Polite , MD;

Corey Shamah , MD;

Mark A. Socinski , MD;

Amanda Barry , MPH;

Kathy Lokay ;

Peter G. Ellis , MD;

Casey Mason ;

Ray Page , DO, PhD, FACOI, FASCO;

Natalie Dickson , MD;

Abstract: Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non–small cell lung cancer (NSCLC), there...

...

02/15/2018

Journal of Clinical Pathways

From the Field

Care Coordination Between Prescribers and the Specialty Pharmacy for Multiple Myeloma: Qualitative Insights Into Designing a Quality Improvement Program for Multisite Community Oncology Practices

08/19/2020

Jeffrey F. Patton , MD;

David Blaisdell , BA;

Jonathan K. Kish , PhD, MPH;

Natalie Dickson , MD;

JaLyna Laney , RN, OCN;

Jesus G. Berdeja , MD;

Stacey W. McCullough , PharmD;

Annette Powers , PharmD, MBA;

Ronda Copher , PhD;

Tom Valuck , MD, JD;

Abstract: It is widely recognized that the quality of medical care received in the United States is suboptimal, and poor-quality care may contribute to disparities in cancer incidence and mortality. While...

...

08/19/2020

Journal of Clinical Pathways